Company profile
STAAR Surgical Company
NASDAQ: STAA · Healthcare · Medical - Instruments & Supplies
#276 of 1,422 Healthcare companies by revenue27th-percentile growth
EA Score
67BFH 66DQ 81GM 31SS 88
v0.1 · 65/100 weight · provisional
↑ disclosure history, listing tenure · ↓ revenue growth (YoY), 3-yr revenue growth
Methodology →Revenue TTM
$290.4M
Rev growth YoY (TTM)
+4.0%
Net income (FY)
-$80.4M
Employees
957
as of 2026-08-09
Market cap
$1.2B
as of 2026-08-09
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$239.4M$239.4M2025
Net income-$80.4M-$80.4M2025
Operating income-$91.7M-$91.7M2025
Total assets$451.7M$451.7M2025
Liabilities$107.5M$107.5M2025
Equity$344.2M$344.2M2025
Revenue trend
FY2021 – FY2025 · USD
FY21
FY21
FY21
FY21
FY22
FY23
FY24
FY25
Revenue by segment
Filed disclosures · FY2024
By product
Implantable Collamer Lenses100%
Other Surgical Products0%
By geography
Not disclosed.
The read
What is STAAR Surgical Company’s revenue?
STAAR Surgical Company booked $239.4M in FY2025 revenue, contracting 24% year over year — slower than 73% of Healthcare companies we track, at a -33.6% net margin.
Peers · Healthcare
Mesa Laboratories, Inc.78B+Keros Therapeutics, Inc.71BDefinitive Healthcare Corp.53DVaxart, Inc.72BOrthoPediatrics Corp.69BAkebia Therapeutics, Inc.66BNeighbors
Orange →Key facts
CEODeborah J. Andrews
SectorHealthcare
IndustryMedical - Instruments & Supplies
HeadquartersLake Forest, CA
ExchangeNASDAQ: STAA
Employees957
IPO date1992-02-24
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.